跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule
Approved
STANDARD
CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
31071d980697152c
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
31071d980697152c
Product Name
CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule
Artg Id
455126
Artg Name
CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2024-07-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
31071d980697152c
Type
Standard
Back to TGA Approvals